Organon& Co. (OGN) Stock Slumping in Premarket, Here’s the Reason

Organon& Co. (OGN), a science-based pharmaceutical company, has declined 13.21% in the premarket trading session and consequently is trading at $28.74 at the time of the writing. During Friday’s regular trading session, the stock gained an increase of 0.61% and closed the day at $33.12. The plunge in aftermarket could be attributed to the Kentucky […]